We developed a method for determining the following ten psychedelic phenethylamines and tryptamines by gas chromatography-mass spectrometry (GC-MS). The phenethylamines examined were 3,4,5-trimethoxyamphetamine ( 
INTRODUCTION
"Designer drugs" or "abused drugs," which are known to cause euphoria and hallucination, when marketed, include the drugs mentioned above in addition to a variety of similar chemically synthesized drugs as well as drugs derived from plants and plant parts such as mushrooms, seeds, and leaves. "Designer drugs" are readily available on the market and can be purchased via the internet; therefore, there is a growing concern that drug abuse has increased due to the fact that it is spreading among the youth. Further, since the components, dosage, and usage of "designer drugs" are unclear, their abuse may damage health and cause harmful symptoms and side effects such as vomiting, headache, memory disorders, and drug psychosis; even social damage might result from hypnotic drug abuse. In order to prevent such damage, it is necessary to analyze and identify the components of such drugs, inform people of the associated risks, and immediately regulate them in case they are deemed to be illegal. However, as there are several types of such drugs, and it is difficult to obtain standards for them; currently, analytical methods [1] [2] [3] [4] [5] [6] have been established for a few drugs. Thus, the aim of this study was to develop sufficiently sensitive identification and quantification methodology for hallucinogenic drugs in commercial products.
In the present study, we chose the following ten compounds ( Fig. 1) as the analytical targets because in our institute we frequently experienced the drug cases which they were determined using mass spectrometry (MS) and nuclear magnetic resonance (NMR). These were as follows: 3,4,5-trimethoxyamphetamine (TMA) and 4-bromo-2,5-dimethoxyphenethylamine (2C-B), which are phenethylamine hallucinogens and have been recently designated as narcotic drugs; and 2,4,5-trimethoxyamphetamine (TMA-2), 4-iodo-2,5-dimethoxyphenethylamine (2C-I), 2,5-dimethoxy-4-ethylthiophenethylamine (2CT-2), 7) 2,5-dimethoxy-4-propylthiophenethylamine (2CT-7), [7] [8] [9] and four designer tryptamines that are their analogs with similar hallucinatory effects. The four designer tryptamines 10, 11) are 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), α-methyltryptamine (AMT), N-isopropyl-5-methoxy-N-methyltryptamine (5-MeO-MIPT), and N,N-diisopropyl-5-methoxytryptamine (5-MeO-DIPT). TMA, TMA-2, 2C-B, 2CT-2, and 2CT-7 were synthesized (Fig. 2) .
2C-I and four tryptamines were isolated and purified from products purchased on the market. We considered the "designer drugs" 12, 13) purchased in the past three years for which analytical methods are established. The proposed method using gas chromatographymass spectrometry (GC-MS) was useful for the determination of drug abuse, sufficiently sensitive and simultaneous.
MATERIALS AND METHODS
Reagents --Chemicals: AMT (> 99%) was sourced from Aldrich (Mil, WI, U.S.A). Nitroethane, acetic acid, ammonium acetate, tetrahydrofuran (THF), LiAlH 4 , hydrochloric acid, dichloromethane, ethyl bromide, Nmethylformanilide, chloroform, acetonitrile, and methanol (all of analytical grade) were purchased from Wako (Osaka, Japan). Water was purified using a Milli-Q water purification unit (Nihon Millipore, Tokyo, Japan). Test solutions: These were prepared according to the General Tests and General Notices of the Japanese Pharmacopoeia. 14) Samples --178 products purchased at adult shops or via the Internet over the past two years in Japan were used as samples. Preparation of Standards from the Products --2C-I, 5-MeO-DMT, 5-MeO-MIPT, and 5-MeO-DIPT were separated and purified from "designer drugs" on the market. The purified compounds were ascertained by GC-MS and NMR. Separation and Clean-up --2C-I, 5-MeO-DMT, 5-MeO-MIPT, and 5-MeO-DIPT: Each of these commercial products was dissolved in 0.02 mol/l hydrochloric acid. Extractions were then performed with chloroform from the ammonia alkaline solutions and the chloroform layer was filtered. The filtrate was evaporated to remove the solvent and purified 2C-I, 5-MeO-DMT, 5-MeO-MIPT, and 5-MeO-DIPT were then obtained for use. Synthesis of Standards --TMA-2, TMA, 2C-B, 2CT-2, and 2CT-7 were synthesized (Fig. 2) . 15, 16) The synthesized compounds were ascertained by GC-MS and NMR. Synthesis --TMA-2, TMA, 2C-B, 2CT-2, and 2CT-7 were synthesized as follows by the method of Shulgin. 15) TMA-2: A solution of [a]-1 (2.5 g, 12.7 mmol) in nitroethane was refluxed in the presence of acetic acid and ammonium acetate for 2 hr. The excess nitroethane was removed, and the deep orange oily residue was drained. These were washed with MeOH and air dried. A yellow needle-like crystal, [a]-2, was then obtained by the usual method. After dissolving [a]-2 in THF and adding LiAlH 4 in anhydrous Et 2 O, the solution was refluxed for 4 hr. The excess LiAlH 4 was subsequently decomposed, and the solution was filtered after treatment with potassium sodium tartrate. The filtrate was evaporated under vacuum and concentrated hydrochloric acid was added to form TMA-2 hydrochloride (1.4 g, yield of 42%).
TMA: The same procedure as that followed for TMA-2 hydrochloride was followed, using [a]-1 (4.0 g, 20 mmol) as a starting material. There was an immediate formation of the anhydrous salt TMA hydrochloride (1.5 g, yield of 30%) 2C-B: A solution of [b]-1 (5 g, 32 mmol) in nitromethane was refluxed in the presence of anhydrous ammonium acetate for 2.5 hr, the residue crystallized spontaneously. This crude nitrostyrene was purified by grinding with isopropyl alcohol (IPA), filtering, and the air-drying to obtain 2,5-dimethoxy-β-nitrostyrene.
[b]-2 was obtained by 1 H, m), 3.79 (3 H, s) NMR --1 H-and 13 C-NMR spectra were obtained on a JEOL (Tokyo, Japan) JNM-ECA500 instrument at 500 MHz and 125 MHz, respectively, with Tetra-methyl-silane as the internal standard. NMR: Approximately 10.0 mg of each sample was dissolved in 1 ml of heavy methanol or chloroform. Sample Preparation --As described below, test solutions were prepared for the synthetic and commercial powdered samples and 0.1 ml of the samples was distilled to prepare test solutions for the commercial liquid products. GC-MS: Approximately 10.0 mg of each sample was dissolved in 20 ml of methanol. The solvent was diluted ten times with acetonitrile. 
GC-MS --GC-MS

RESULTS AND DISCUSSION
GC-MS of Standard Compounds
The ten components were well separated in the GC (Fig. 3) . The EI mass spectra resulting from the GC-MS analysis of the phenethylamines and tryptamines are presented in Fig. 4 . Figure 4 describes the fragmentation patterns. The α-fission process is expected to produce fragment m/z 44 The accuracy of the procedure was determined by spiking a placebo formulation with a known concentration (50 ppm) of the standard. The recoveries were between 92 and 98% (n = 5). The C.V. values (n = 5) were between 2 and 5%. 
Analysis of Commercial Products
The compounds of the commercial products were identified and quantified using hydrochlorides of synthesized compounds TMA-2, TMA, 2C-B, 2CT-2, and 2CT-7, and purified compounds 2C-I, 5-MeO-DMT, 5-MeO-MIPT, and 5-MeO-DIPT as the standards by GC-MS. The other methodologies (GC, high-performance liquid chromatography, ultra-violet absorption spectroscopy) were additionally utilized for further identification (data not shown). The quantifications were carried out according to the GC-MS (Selected ion monitoring) tests and the absolute calibration curve method.
Between April 2005 and March 2007, 178 products were purchased from stores and through the internet and were subsequently examined. The products in which either within the ten compounds was detected are listed in Table 1 . The results of the quantitative analyses of the "designer drugs," which were mixtures of several drugs, are shown in Table 2 . In the "designer drugs," several series such as piperazine series, e.g., 1-(3-chlorophyle)- In conclusions, the efficacy of the test methods for identifying and quantifying the ten phenethylamine and tryptamine compounds was examined by testing the hallucinogens used for the so-called "designer drugs" or "abused drugs." Since it was difficult to obtain standards for any of the components, the synthetic compounds and isolated and purified compounds were used as the standards for the tests. The results revealed the ten compounds to be satisfactorily identified and simultaneously quantified using MS. GC-MS (SIM) method was found to be sufficiently sensitive for the determination of the ten compoumds in the range of micrograms using 10 mg samples. Although all the components used in the present study are regulated by various legislations (the "Narcotics and Stimulants Control Law" and the "Pharmaceutical Affairs Law"), there are several analogs such as 2C-C: 4-chloro-2,5-dimethoxyphenethylamine, 2C-E: 2,5-dimethoxy-4-ethylphenethylamine, and 2CT-4: 2,5-dimethoxy-4-isopropylthiophenethylamine. Therefore, the present analytical method should be further examined to deal with these compounds.
